LifeTech Scientific Corporation (HKG:1302)

LifeTech Scientific Revenue

LifeTech Scientific had revenue of 600.83M CNY in the half year ending June 30, 2026, a decrease of -7.97%. This brings the company's total for the last twelve months to 1.29B, down -2.54% year-over-year. In the year 2025, LifeTech Scientific had annual revenue of 1.37B with 5.07% growth. That makes LifeTech Scientific the 17,815th largest company in the world by revenue and 1,035th in Hong Kong.

• Revenue (ttm): 1.29B CNY
• Revenue Growth: -2.54%
• P/S Ratio: 4.79
• Revenue / Employee: 1.03M CNY
• Employees: 1,254
• Market Cap: 7.02B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Segment

By Segment

Chart

• Peripheral Vascular Diseases Business 844.63M 61.7%
• Structural Heart Diseases Business 511.68M 37.4%
• Cardiac Pacing and Electrophysiology Business 13.48M 1.0%

By Geography

Chart

• Mainland China 973.35M 71.1%
• Europe 165.86M 12.1%
• Asia (Excluding Mainland China and India) 105.40M 7.7%
• India 57.32M 4.2%
• South America 39.74M 2.9%
• Africa 22.87M 1.7%
• Others 5.24M 0.4%

Fiscal year ended Dec 31, 2025 See the full LifeTech Scientific breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.37B	66.08M	5.07%
Dec 31, 2024	1.30B	36.52M	2.88%
Dec 31, 2023	1.27B	169.87M	15.48%
Dec 31, 2022	1.10B	171.98M	18.59%
Dec 31, 2021	925.33M	283.04M	44.07%

Data Source: S&P Global Market Intelligence Last updated: Sep 11, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 18, 2026

Data Sources Report a data error